These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 8821041)
21. Research in motion: the enigma of Parkinson's disease pathology spread. Brundin P; Li JY; Holton JL; Lindvall O; Revesz T Nat Rev Neurosci; 2008 Oct; 9(10):741-5. PubMed ID: 18769444 [TBL] [Abstract][Full Text] [Related]
22. From transplants to gene therapy for Parkinson's disease. Freeman TB Exp Neurol; 1997 Mar; 144(1):47-50. PubMed ID: 9126151 [TBL] [Abstract][Full Text] [Related]
23. [Cell therapy and other neuroregenerative strategies in Parkinson's disease (I)]. Mínguez-Castellanos A; Escamilla-Sevilla F Rev Neurol; 2005 Nov 16-30; 41(10):604-14. PubMed ID: 16288424 [TBL] [Abstract][Full Text] [Related]
24. Emerging restorative treatments for Parkinson's disease. Deierborg T; Soulet D; Roybon L; Hall V; Brundin P Prog Neurobiol; 2008 Aug; 85(4):407-32. PubMed ID: 18586376 [TBL] [Abstract][Full Text] [Related]
25. The current state of free radicals in Parkinson's disease. Nigral iron as a trigger of oxidative stress. Friedman A; Galazka-Friedman J Adv Neurol; 2001; 86():137-42. PubMed ID: 11553971 [No Abstract] [Full Text] [Related]
26. Oxidative mechanisms in nigral cell death in Parkinson's disease. Jenner P Mov Disord; 1998; 13 Suppl 1():24-34. PubMed ID: 9613715 [TBL] [Abstract][Full Text] [Related]
27. Olfactory mucosa is a potential source for autologous stem cell therapy for Parkinson's disease. Murrell W; Wetzig A; Donnellan M; Féron F; Burne T; Meedeniya A; Kesby J; Bianco J; Perry C; Silburn P; Mackay-Sim A Stem Cells; 2008 Aug; 26(8):2183-92. PubMed ID: 18535154 [TBL] [Abstract][Full Text] [Related]
28. alpha-Synuclein, oxidative stress and apoptosis from the perspective of a yeast model of Parkinson's disease. Witt SN; Flower TR FEMS Yeast Res; 2006 Dec; 6(8):1107-16. PubMed ID: 17156009 [TBL] [Abstract][Full Text] [Related]
29. Mechanisms of Parkinson's disease. Br Med J; 1978 Apr; 1(6117):872-3. PubMed ID: 25109 [No Abstract] [Full Text] [Related]
30. Neurotoxicity and the mechanisms of cell death in Parkinson's disease. Schapira AH Adv Neurol; 1996; 69():161-5. PubMed ID: 8615125 [No Abstract] [Full Text] [Related]
31. Optogenetic neuromodulation. Kalanithi PS; Henderson JM Int Rev Neurobiol; 2012; 107():185-205. PubMed ID: 23206683 [TBL] [Abstract][Full Text] [Related]
32. [Physiopathology of Parkinson's disease]. Arnoud B Soins; 1986 Mar; (474):3-6. PubMed ID: 2875524 [No Abstract] [Full Text] [Related]